Horizon Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200K Buy
3,300
+598
+22% +$34.9K 0.1% 76
2025
Q4
$146K Sell
2,702
-144
-5% -$6.93K 0.07% 92
2025
Q3
$128K Buy
2,846
+1,002
+54% +$46.8K 0.06% 98
2025
Q2
$85K Sell
1,844
-60
-3% -$2.94K 0.04% 127
2025
Q1
$116K Sell
1,904
-271
-12% -$15.8K 0.07% 90
2024
Q4
$123K Buy
2,175
+12
+0.6% +$670 0.06% 88
2024
Q3
$112K Sell
2,163
-74
-3% -$3.47K 0.05% 100
2024
Q2
$93K Buy
2,237
+350
+19% +$15.7K 0.04% 104
2024
Q1
$102K Buy
1,887
+86
+5% +$4.38K 0.05% 109
2023
Q4
$92K Buy
1,801
+78
+5% +$4.09K 0.05% 109
2023
Q3
$100K Buy
1,723
+1,443
+515% +$88.4K 0.06% 89
2023
Q2
$18K Buy
+280
New +$18.8K 0.01% 163
2023
Q1
Sell
-3,900
Closed -$281K 186
2022
Q4
$281K Buy
+3,900
New +$294K 0.16% 35
2020
Q3
$854K Buy
14,165
+69
+0.5% +$4.15K 1.21% 15
2020
Q2
$829K Sell
14,096
-922
-6% -$55.1K 0.89% 11
2020
Q1
$837K Sell
15,018
-7,057
-32% -$431K 1.29% 10
2019
Q4
$1.42M Buy
+22,075
New +$1.26M 1.33% 9

Other funds holding BMY

Horizon Bancorp's BMY Position: Q1 2026 in Review

Horizon Bancorp increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2026, buying an estimated $34.9K and bringing the position to 3,300 shares worth $200K. The position accounts for 0.1% of the portfolio, ranked #76.

Horizon Bancorp first reported a position in BMY in Q4 2019 and has held it in 17 quarters since. The position peaked at $1.42M in Q4 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Horizon Bancorp held 3,300 shares of Bristol-Myers Squibb worth $200K as of Q1 2026.
  • Horizon Bancorp bought 598 Bristol-Myers Squibb shares in Q1 2026, an estimated $34.9K.
  • Bristol-Myers Squibb made up 0.1% of Horizon Bancorp's portfolio in Q1 2026, its #76 holding.
  • Horizon Bancorp first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 17 quarters since.
  • Horizon Bancorp's Bristol-Myers Squibb position peaked at $1.42M in Q4 2019.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.